Co-Authors
This is a "connection" page, showing publications co-authored by MICHAEL ELLIOT KUPFERMAN and SHAAN MOHAMMED RAZA.
Connection Strength
2.481
-
Long-term oncological outcomes for endoscopic endonasal versus open surgical approaches for anatomically matched, locally advanced stage T4 sinonasal malignancies with skull base involvement. J Neurosurg. 2024 Mar 01; 140(3):688-695.
Score: 0.233
-
Predictors of postoperative performance status after surgical management of infratemporal fossa malignancies. Neurosurg Rev. 2023 Jun 29; 46(1):157.
Score: 0.229
-
Soft Tissue Sarcomas of the Head and Neck Region with Skull Base/Intracranial Invasion: Review of Surgical Outcomes and Multimodal Treatment Strategies: A Retrospective Case Series. Curr Oncol. 2022 09 14; 29(9):6540-6550.
Score: 0.217
-
The impact of expanded endoscopic approaches on oncologic and functional outcomes for clival malignancies:a case series. J Neurooncol. 2022 Sep; 159(3):627-635.
Score: 0.216
-
Impact of salvage surgery for recurrent sinonasal cancers with skull base and intracranial involvement. J Neurosurg. 2022 Oct 01; 137(4):961-968.
Score: 0.208
-
Surgical management of carcinomas of the infratemporal fossa and skull base: patterns of failure and predictors of long-term outcomes. J Neurosurg. 2021 05 01; 134(5):1392-1398.
Score: 0.186
-
Endoscopic endonasal transpterygoid transnasopharyngeal management of petroclival chondrosarcomas without medial extension. J Neurosurg. 2019 07 01; 131(1):184-191.
Score: 0.163
-
Site-Specific Considerations in the Surgical Management of Skull Base Chondrosarcomas. Oper Neurosurg (Hagerstown). 2018 06 01; 14(6):611-619.
Score: 0.161
-
Impact of early access to multidisciplinary care on treatment outcomes in patients with skull base chordoma. Acta Neurochir (Wien). 2018 04; 160(4):731-740.
Score: 0.156
-
Nonmelanoma cutaneous cancers involving the skull base: outcomes of aggressive multimodal management. J Neurosurg. 2015 Sep; 123(3):781-8.
Score: 0.130
-
The neurosurgical management of sinonasal malignancies involving the anterior skull base: a 28-year experience at The MD Anderson Cancer Center. J Neurosurg. 2022 Jun 01; 136(6):1583-1591.
Score: 0.051
-
Long-Term Outcomes of Olfactory Neuroblastoma: MD Anderson Cancer Center Experience and Review of the Literature. Laryngoscope. 2022 02; 132(2):290-297.
Score: 0.050
-
Neoadjuvant chemotherapy for locoregionally advanced squamous cell carcinoma of the paranasal sinuses. Cancer. 2021 06 01; 127(11):1788-1795.
Score: 0.049
-
Clinical Implication of Diagnostic and Histopathologic Discrepancies in Sinonasal Malignancies. Laryngoscope. 2021 05; 131(5):E1468-E1475.
Score: 0.047
-
Endoscopic resection of sinonasal malignancies. Head Neck. 2020 04; 42(4):645-652.
Score: 0.045
-
Induction Chemotherapy Response as a Guide for Treatment Optimization in Sinonasal Undifferentiated Carcinoma. J Clin Oncol. 2019 02 20; 37(6):504-512.
Score: 0.042
-
Prognostic factors and survival in adenoid cystic carcinoma of the sinonasal cavity. Head Neck. 2018 12; 40(12):2596-2605.
Score: 0.042
-
Patterns of Treatment Failure in Patients with Sinonasal Mucosal Melanoma. Ann Surg Oncol. 2018 Jun; 25(6):1723-1729.
Score: 0.040
-
Early Stage olfactory neuroblastoma and the impact of resecting dura and olfactory bulb. Laryngoscope. 2018 06; 128(6):1274-1280.
Score: 0.039
-
Approaches to regional lymph node metastasis in patients with head and neck mucosal melanoma. Cancer. 2018 02 01; 124(3):514-520.
Score: 0.039
-
Role of Adjuvant Treatment in Sinonasal Mucosal Melanoma. J Neurol Surg B Skull Base. 2017 Dec; 78(6):512-518.
Score: 0.038
-
Mutation status among patients with sinonasal mucosal melanoma and its impact on survival. Br J Cancer. 2017 Jun 06; 116(12):1564-1571.
Score: 0.037
-
Adenoid cystic carcinoma of the skull base: results with an aggressive multidisciplinary approach. J Neurosurg. 2016 Jan; 124(1):115-21.
Score: 0.033
-
Endoscopic resection of sinonasal cancers. Curr Oncol Rep. 2014 Feb; 16(2):369.
Score: 0.030